How generative AI is building better antibodies

2 min read Original article ↗
  • NEWS

Language models similar to those behind ChatGPT have been used to improve antibody therapies against COVID-19, Ebola and other viruses.

At the height of the pandemic, researchers raced to develop some of the first effective treatments against COVID-19: antibody molecules isolated from the blood of people who had recovered from the disease.

Access options

Access Nature and 54 other Nature Portfolio journals

Get Nature+, our best-value online-access subscription

$32.99 / 30 days

cancel any time

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Nature 617, 235 (2023)

doi: https://doi.org/10.1038/d41586-023-01516-w

References

  1. Hie, B. L. et al. Nature Biotechnol. https://doi.org/10.1038/s41587-023-01763-2 (2023).

    Article  PubMed  Google Scholar 

  2. Shanehsazzadeh, A. et al. Preprint at BioRxiv https://doi.org/10.1101/2023.01.08.523187 (2023).

  3. Eguchi, R. R. et al. Preprint at BioRxiv https://doi.org/10.1101/2022.12.22.521698 (2022).

Download references

Subjects

Latest on: